BALYASNY ASSET MANAGEMENT L.P. - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 82 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$218,000
+156.5%
57,626
+243.8%
0.00%
Q2 2018$85,000
+23.2%
16,760
+39.7%
0.00%
Q3 2017$69,00012,0000.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,196,527$16,526,0003.00%
BVF INC/IL 5,328,239$27,547,0001.08%
Soleus Capital Management, L.P. 740,000$3,826,0000.60%
Cutter & CO Brokerage, Inc. 326,100$1,686,0000.40%
EAM Investors, LLC 288,459$1,491,0000.25%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$5,316,0000.15%
Rhenman & Partners Asset Management AB 300,000$1,551,0000.11%
Navis Wealth Advisors, LLC 16,000$83,0000.06%
Sigma Planning Corp 364,484$1,884,0000.06%
XTX Topco Ltd 32,650$169,0000.06%
View complete list of PIERIS PHARMACEUTICALS INC shareholders